Familial Pancreatic Cancer
10
3
6
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
Cohort Study of Pancreatic Cancer Risk
DCE MRI in Patients With Pancreatic Cancer
PREVENPANC Project: a Spanish Multicenter Study for Pancreatic Cancer Prevention
Pancreatic Cancer Early Detection Program
Quebec Pancreas Cancer Study
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
Understanding Genetic Incidental Findings in Your Family (UNIFY Study)
Registry of Subjects at Risk of Pancreatic Cancer
A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups